Brain 17 Vienna

PROFILE trial 1014 (crizotinib vs chemotherapy)

intracranial progression free survival of pts without BM

Crizotinib

Chemotherapy

Brain metastases in patients with ALK-positive NSCLC

BM - brain metastases

Solomon et al 2016, J Clin Oncol; 34 (24), 2858-65